Back to User profile » Dr Jeng-Sen Tseng

Papers published by Dr Jeng-Sen Tseng:


Outcome of Thromboembolic Events and Its Influence on Survival Time of Advanced NSCLC Patients Treated with Antiangiogenic Therapy

Ou WF, Liao PY, Hsu YW, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY

Cancer Management and Research 2023, 15:1251-1262

Published Date: 6 November 2023

The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib

Chen KC, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY

OncoTargets and Therapy 2023, 16:317-326

Published Date: 17 May 2023

Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients

Hsu KH, Huang JW, Tseng JS, Chen KW, Weng YC, Yu SL, Yang TY, Huang YH, Chen JJW, Chen KC, Chang GC

OncoTargets and Therapy 2021, 14:2139-2148

Published Date: 25 March 2021

Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemonaïve patients with EGFR-mutant lung adenocarcinoma

Tseng JS, Yang TY, Chen KC, Hsu KH, Yu CJ, Liao WY, Tsai CR, Tsai MH, Yu SL, Su KY, Chen JJ, Chen HY, Chang GC

OncoTargets and Therapy 2014, 7:799-805

Published Date: 23 May 2014